Results 171 to 180 of about 951,374 (223)

Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection. [PDF]

Nat Commun
Santos-Peral A, Luppa F, Goresch S, Nikolova E, Zaucha M, Lehmann L, Dahlstroem F, Karimzadeh H, Thorn-Seshold J, Winheim E, Schuster EM, Dobler G, Hoelscher M, Kümmerer BM, Endres S, Schober K, Krug AB, Pritsch M, Barba-Spaeth G, Rothenfusser S.   +19 more
europepmc   +1 more source

Crepe Fever [PDF]

, 2012
Crepe Fever (Restaurant)
core   +1 more source

Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics. [PDF]

Braz J Infect Dis
Motta E, Camacho LAB, Filippis AMB, Costa M, Pedro L, Cardoso SW, Souza MCO, Mendes YDS, Grinsztejn B, Coelho LE.   +9 more
europepmc   +1 more source

Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9-23 months old in Uganda, 2019-2020 - Preliminary report. [PDF]

Vaccine
Casey RM, Najjengo MS, Lubega I, Sekiziyivu AB, Twinomuhwezi-Oyet E, Nakato WN, Sciarratta CN, Chu SY, Doshi RH, Kambugu A, Gidudu JF.   +10 more
europepmc   +1 more source

Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study. [PDF]

Lancet Infect Dis
Doshi RH, Mukadi PK, Casey RM, Kizito GM, Gao H, Nguete U B, Laven J, Sabi L, Kaba DK, Muyembe-Tamfum JJ, Hyde TB, Ahuka-Mundeke S, Staples JE.   +12 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Current assessment of yellow fever and yellow fever vaccine

Current Infectious Disease Reports, 2004
Yellow fever (YF) is a mosquito-borne viral illness that causes hemorrhagic fever in tropical Africa and South America. Although a very safe and efficient vaccine (17D) is available, it is underused. An estimated 200,000 people are still infected annually, and YF remains a major public health concern.
Anabelle, Lefeuvre, Philippe, Marianneau, Vincent, Deubel   +2 more
openaire   +2 more sources

Yellow fever vaccine: worthy friend or stealthy foe?

Expert Review of Vaccines, 2016
Recognition that the live yellow fever vaccine may rarely be associated with viscerotropic disease (YEL-AVD) has diminished its safety status. However, the vaccine remains the principal tool for limiting the occurrence of yellow fever, making large ...
Stephen J Seligman, Jean-Laurent Casanova   +1 more
exaly   +2 more sources